Biological Products, Except Diagnostic Substances
Stocks Ranked by
Market Capitalization

Filters

#	Name	Market cap	Price	Price change %
1	1 Amgen AMGN $172B	$172B	$320.56	-1.17%
2	2 Gilead Sciences GILD $98.1B	$98.1B	$78.72	-0.32%
3	3 Biogen BIIB $29.2B	$29.2B	$200.81	-0.64%
4	4 Moderna MRNA $28B	$28B	$72.89	-1.65%
5	5 Vaxcyte PCVX $12.5B	$12.5B	$111.58	-0.46%
6	6 Neurocrine Biosciences NBIX $12.1B	$12.1B	$120.17	-0.86%
7	7 Bio-Techne TECH $11.3B	$11.3B	$71.49	-1.22%
8	8 Repligen RGEN $8.24B	$8.24B	$147.07	+1.31%
9	9 Halozyme HALO $7.5B	$7.5B	$59.21	-3.01%
10	10 Exelixis EXEL $7.17B	$7.17B	$25.15	-1.72%
11	11 Revolution Medicines RVMD $6.99B	$6.99B	$41.84	-3.24%
12	12 Krystal Biotech KRYS $5.29B	$5.29B	$184.19	-1.01%
13	13 Immunovant IMVT $4.98B	$4.98B	$34.03	+1.13%
14	14 Arcellx ACLX $3.83B	$3.83B	$71.25	+1.25%
15	15 CRISPR Therapeutics CRSP $3.8B	$3.8B	$44.62	-0.77%
16	16 ADMA Biologics ADMA $3.79B	$3.79B	$16.26	+1.49%
17	17 Denali Therapeutics DNLI $3.61B	$3.61B	$25.25	+0%
18	18 Iovance Biotherapeutics IOVA $3.04B	$3.04B	$10.01	-2.01%
19	19 Kymera Therapeutics KYMR $2.93B	$2.93B	$45.40	-2.58%
20	20 SpringWorks Therapeutics SWTX $2.88B	$2.88B	$38.75	-3.41%
21	21 Apogee Therapeutics APGE $2.68B	$2.68B	$47.25	-2.05%
22	22 CG Oncology CGON $2.55B	$2.55B	$38.05	+1.3%
23	23 ImmunityBio IBRX $2.35B	$2.35B	$3.38	+0%
24	24 Vericel Corp VCEL $2.2B	$2.2B	$45.22	-3.99%
25	25 Twist Bioscience TWST $2.15B	$2.15B	$36.72	-8.25%